235 related articles for article (PubMed ID: 26210997)
41. Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals.
Tichon A; Gowda BK; Slavin S; Gazit A; Priel E
Cytotherapy; 2009; 11(7):837-48. PubMed ID: 19903097
[TBL] [Abstract][Full Text] [Related]
42. Alterations of mesenchymal stromal cells in cerebrospinal fluid: insights from transcriptomics and an ALS clinical trial.
Krull AA; Setter DO; Gendron TF; Hrstka SCL; Polzin MJ; Hart J; Dudakovic A; Madigan NN; Dietz AB; Windebank AJ; van Wijnen AJ; Staff NP
Stem Cell Res Ther; 2021 Mar; 12(1):187. PubMed ID: 33736701
[TBL] [Abstract][Full Text] [Related]
43. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
Baek W; Kim YS; Koh SH; Lim SW; Kim HY; Yi HJ; Kim H
J Neurosurg Sci; 2012 Sep; 56(3):261-3. PubMed ID: 22854595
[TBL] [Abstract][Full Text] [Related]
44. DNA Methyltransferases Modulate Hepatogenic Lineage Plasticity of Mesenchymal Stromal Cells.
Lee CW; Huang WC; Huang HD; Huang YH; Ho JH; Yang MH; Yang VW; Lee OK
Stem Cell Reports; 2017 Jul; 9(1):247-263. PubMed ID: 28602611
[TBL] [Abstract][Full Text] [Related]
45. The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy - a perspective on cell biological mechanisms.
Tang BL
Rev Neurosci; 2017 Oct; 28(7):725-738. PubMed ID: 28599400
[TBL] [Abstract][Full Text] [Related]
46. Effect of DNMT inhibitor on bovine parthenogenetic embryo development.
Zhang S; Tang B; Fan C; Shi L; Zhang X; Sun L; Li Z
Biochem Biophys Res Commun; 2015 Oct; 466(3):505-11. PubMed ID: 26381173
[TBL] [Abstract][Full Text] [Related]
47. Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research.
Frausin S; Viventi S; Verga Falzacappa L; Quattromani MJ; Leanza G; Tommasini A; Valencic E
Acta Histochem; 2015; 117(4-5):329-38. PubMed ID: 25747736
[TBL] [Abstract][Full Text] [Related]
48. Paracrine effects of mesenchymal stem cells induce senescence and differentiation of glioblastoma stem-like cells.
Kološa K; Motaln H; Herold-Mende C; Koršič M; Lah TT
Cell Transplant; 2015; 24(4):631-44. PubMed ID: 25806680
[TBL] [Abstract][Full Text] [Related]
49. Transplantation of mesenchymal stem cells in ALS.
Mazzini L; Vercelli A; Ferrero I; Boido M; Cantello R; Fagioli F
Prog Brain Res; 2012; 201():333-59. PubMed ID: 23186722
[TBL] [Abstract][Full Text] [Related]
50. Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
Oh KW; Noh MY; Kwon MS; Kim HY; Oh SI; Park J; Kim HJ; Ki CS; Kim SH
Ann Neurol; 2018 Sep; 84(3):361-373. PubMed ID: 30048006
[TBL] [Abstract][Full Text] [Related]
51. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells.
Nicaise C; Mitrecic D; Pochet R
Neuropathol Appl Neurobiol; 2011 Feb; 37(2):179-88. PubMed ID: 20846186
[TBL] [Abstract][Full Text] [Related]
52. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
Borghese C; Cattaruzza L; Pivetta E; Normanno N; De Luca A; Mazzucato M; Celegato M; Colombatti A; Aldinucci D
J Cell Biochem; 2013 May; 114(5):1135-44. PubMed ID: 23192362
[TBL] [Abstract][Full Text] [Related]
53. Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis.
De Marchi F; Mareschi K; Ferrero I; Cantello R; Fagioli F; Mazzini L
Cytotherapy; 2023 Aug; 25(8):798-802. PubMed ID: 36931995
[TBL] [Abstract][Full Text] [Related]
54. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
55. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC
Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874
[TBL] [Abstract][Full Text] [Related]
57. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats.
Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK
Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583
[TBL] [Abstract][Full Text] [Related]
58. An in vitro expansion score for tissue-engineering applications with human bone marrow-derived mesenchymal stem cells.
Bertolo A; Mehr M; Janner-Jametti T; Graumann U; Aebli N; Baur M; Ferguson SJ; Stoyanov JV
J Tissue Eng Regen Med; 2016 Feb; 10(2):149-61. PubMed ID: 23576360
[TBL] [Abstract][Full Text] [Related]
59. [Stem cells therapy in amyotrophic lateral sclerosis treatment. A critical view].
Soler B; Fadic R; von Bernhardi R
Rev Neurol; 2011 Apr; 52(7):426-34. PubMed ID: 21425112
[TBL] [Abstract][Full Text] [Related]
60. Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis.
Tavakol-Afshari J; Boroumand AR; Farkhad NK; Adhami Moghadam A; Sahab-Negah S; Gorji A
Regen Ther; 2021 Dec; 18():268-274. PubMed ID: 34466632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
